Assessing biosafety using NGS-based tests requires a continuum of skills in molecular biology, biocomputing, virology, and quality systems.
Audrey Brussel
Advertisement
Audrey Brussel, PhD, audrey.brussel@pathoquest.com, is Viral Safety leader at PathoQuest.
Articles by Audrey Brussel
Advertisement
Latest Updated Articles
Challenges When Outsourcing Viral Safety ServicesMay 15th 2021
Advertisement
Advertisement
Trending on BioPharm International
1
Zylidac Bio to Scale Prolific's Optogenetic Cell Line Platform to GMP
2
BioNTech, BMS to Pair Pumitamig With Trodelvy in Phase 3 First-Line TNBC Trial
3
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
4
FDA Grants Accelerated Approval to Ultomiris as First C5 Inhibitor for IgA Nephropathy
5